Home > Healthcare > Medical Devices > Therapeutic Devices > Atrial Fibrillation Devices Market

Atrial Fibrillation Devices Market Trends

  • Report ID: GMI3165
  • Published Date: Sep 2024
  • Report Format: PDF

Atrial Fibrillation Devices Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous innovations in technology, growing demand for minimally invasive procedures, growing adoption of wearable and remote monitoring devices, and increasing use of hybrid procedures, among other factors are propelling the industry growth.
 

  • One of the most significant trends in the atrial fibrillation (AF) devices market is the growing preference for minimally invasive procedures. Catheter ablation, which involves using heat or cold to destroy the tissue causing irregular heartbeats, is becoming increasingly popular due to its effectiveness and quicker recovery times. This trend is driving the development and adoption of advanced ablation catheters and other minimally invasive devices, making AF treatments less invasive and more patient-friendly.
     
  • Moreover, with the rise of digital health, there is an increasing trend towards the use of wearable devices and remote monitoring systems for managing atrial fibrillation. These devices allow continuous monitoring of heart rhythm, enabling early detection of AF episodes and timely intervention. The integration of artificial intelligence (AI) and machine learning algorithms into these devices is further enhancing their diagnostic capabilities, leading to better patient outcomes and more proactive management of AF.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global atrial fibrillation devices industry was valued at USD 10.6 billion in 2023 and is expected to exhibit 11.5% CAGR from 2024 – 2032 attributed to the rising prevalence of atrial fibrillation, and growing awareness and early diagnosis

The hospitals end-use segment in the market is anticipated to reach USD 12.3 billion by 2032 led by the growing demand for specialized treatment centers dedicated to managing atrial fibrillation

North America atrial fibrillation devices industry size is anticipated to grow at 11.3% CAGR between 2024 and 2032 backed by aging population and the increasing incidence of lifestyle-related conditions, such as obesity, hypertension, and diabetes

Abbott Laboratories, Acutus Medical, Inc., AtriCure, Inc., Biotronik, Boston Scientific Corporation, CardioFocus, CathRx Ltd., Hansen Medical, Inc., Imricor, Johnson and Johnson (Biosense Webster), and Medtronic plc

Atrial Fibrillation Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 145
  • Countries covered: 23
  • Pages: 100
 Download Free Sample